Treatment of viral myocarditis with focus on captopril
- 15 March 1996
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 77 (8) , 634-637
- https://doi.org/10.1016/s0002-9149(97)89320-4
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.Journal of Clinical Investigation, 1993
- Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in miceCardiovascular Research, 1992
- The effect of .ALPHA.1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.Japanese Circulation Journal, 1992
- Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditisAmerican Heart Journal, 1990
- Management strategies in viral myocarditisAmerican Heart Journal, 1989
- Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in miceAmerican Heart Journal, 1988
- Treatment of viral myocarditis with ribavirin in an animal preparation.Circulation, 1985
- Diagnosis and Classification of Myocarditis by Endomyocardial BiopsyNew England Journal of Medicine, 1983
- A Mouse Model of Transmural Myocardial Necrosis Due to Coxsackievirus B4: Observations over 12 MonthsIntervirology, 1981
- Immunosuppressive therapy in patients with congestive cardiomyopathy and myocardial uptake of gallium-67.Circulation, 1981